Frank Buttgereit
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 278 publications
Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica.
Journal: The New England journal of medicine
Published: June 03, 2026
Low-dose and very low-dose glucocorticoids: which low is low risk? - Authors' reply.
Journal: The Lancet. Rheumatology
Published: May 19, 2026
Comment on: Recommendations of the German, Austrian and Swiss rheumatology and other medical societies for the management of polymyalgia rheumatica: Reply.
Journal: Rheumatology (Oxford, England)
Published: May 12, 2026
2025 EULAR recommendations for the management of polymyalgia rheumatica and primary large vessel vasculitis.
Journal: Annals of the rheumatic diseases
Published: March 31, 2026
Teclistamab for treatment-refractory autoimmune diseases: a multicentre case series.
Journal: Annals of the rheumatic diseases
Published: January 19, 2026
Novel glucocorticoids: current status and challenges.
Journal: Rheumatology (Oxford, England)
Published: December 15, 2025
A Delphi exercise informing the development of criteria to measure response to treatment in giant cell arteritis.
Journal: Seminars in arthritis and rheumatism
Published: November 22, 2025
Achievement and Maintenance of Disease Targets with Upadacitinib in Rheumatoid Arthritis: 2-Year Outcomes from the UPHOLD Real-World Study.
Journal: Rheumatology and therapy
Published: November 18, 2025
Standardizing physical function across assessment types: Three versions of the physical performance test were linked to the PROMIS physical function metric in diverse populations.
Journal: Journal of clinical epidemiology
Published: November 12, 2025
Last Updated: 09/26/2026